+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Appetite (Eating) Disorders Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767651
  • Report
  • 189 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Eli Lilly and Co
  • Endo International Plc
  • Insys Therapeutics Inc
  • Johnson & Johnson
  • QPS Holdings LLC
  • MORE
The global clinical trial report- “2019 Appetite (Eating) Disorders Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Appetite (Eating) Disorders. It presents in-depth analysis of Appetite (Eating) Disorders clinical trials across markets and companies. The research work is for providing complete understanding into trends in Appetite (Eating) Disorders.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Appetite (Eating) Disorders clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Appetite (Eating) Disorders

The research work is prepared through extensive and continuous research on Appetite (Eating) Disorders trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Appetite (Eating) Disorders patients are identified
  • The report includes panorama of Appetite (Eating) Disorders clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Appetite (Eating) Disorders clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Eli Lilly and Co
  • Endo International Plc
  • Insys Therapeutics Inc
  • Johnson & Johnson
  • QPS Holdings LLC
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Appetite (Eating) Disorders Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Appetite (Eating) Disorders Clinical Trials by Region
2.2.2 Average Enrollment of Appetite (Eating) Disorders Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Appetite (Eating) Disorders Treatment, 2019

3. Region wise Appetite (Eating) Disorders Clinical Trials
3.1 Asia Pacific Appetite (Eating) Disorders Clinical Trials by Country
3.2 Europe Appetite (Eating) Disorders Clinical Trials by Country
3.3 North America Appetite (Eating) Disorders Clinical Trials by Country
3.4 Middle East and Africa Appetite (Eating) Disorders Clinical Trials by Country
3.5 South and Central America Appetite (Eating) Disorders Clinical Trials by Country

4. Appetite (Eating) Disorders Clinical Trial Trends
4.1 Start Year wise Appetite (Eating) Disorders Clinical Trials
4.2 Phase wise Appetite (Eating) Disorders Clinical Trials
4.3 Trial Status wise Appetite (Eating) Disorders Clinical Trials
4.4 Trial Type wise Appetite (Eating) Disorders Clinical Trials

5. Appetite (Eating) Disorders Average Enrollment Trends
5.1 Average Enrollment in Appetite (Eating) Disorders Trials by Year
5.2 Average Enrollment in Appetite (Eating) Disorders Trials by Phase
5.3 Average Enrollment in Appetite (Eating) Disorders Trials by Status
5.4 Average Enrollment in Appetite (Eating) Disorders Trials by Type of Trial

6. Companies Participating in Appetite (Eating) Disorders Clinical Trials
6.1 Appetite (Eating) Disorders Trials by Sponsor Type
6.2 Appetite (Eating) Disorders Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Appetite (Eating) Disorders Trials- Phase 1
7.2 Appetite (Eating) Disorders Trials- Phase 2
7.3 Appetite (Eating) Disorders Trials- Phase 3
7.4 Appetite (Eating) Disorders Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Appetite (Eating) Disorders Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Figure 5: Europe - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Figure 7: North America - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Figure 9: Appetite (Eating) Disorders Clinical Trials by Phase
Figure 10: Appetite (Eating) Disorders Clinical Trials by Trial Status
Figure 11: Appetite (Eating) Disorders Clinical Trials by Type
Figure 12: Appetite (Eating) Disorders Clinical Trials by Sponsor Type
Figure 13: Appetite (Eating) Disorders Clinical Trials by Leading Sponsors
Figure 14: Appetite (Eating) Disorders Average Enrollment by Phase
Figure 15: Appetite (Eating) Disorders Average Enrollment by Trial Status
Figure 16: Appetite (Eating) Disorders Average Enrollment by Type
Figure 17: Appetite (Eating) Disorders- Average Enrolment by Type of Sponsors
Figure 18: Appetite (Eating) Disorders- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Appetite (Eating) Disorders Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Table 5: Europe - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Table 7: North America - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Appetite (Eating) Disorders Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Appetite (Eating) Disorders Average Enrollment by Phase
Table 15: Appetite (Eating) Disorders Average Enrollment by Trial Status
Table 16: Appetite (Eating) Disorders Average Enrollment by Type
Table 17: Appetite (Eating) Disorders- Average Enrolment by Type of Sponsors
Table 18: Appetite (Eating) Disorders- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc
  • Eli Lilly and Co
  • Endo International Plc
  • Insys Therapeutics Inc
  • Johnson & Johnson
  • Opiant Pharmaceuticals Inc
  • QPS Holdings LLC
  • Radiant Research Inc
  • Shire Plc
  • Tsumura & co
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767651
Adroll
adroll